Clinical Trial Update: Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major

View source ↗

Summary

Clinical trial update describing monitoring of erythroid lineage–specific chimerism after allogeneic hematopoietic transplantation in patients with Thalassemia …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia Major

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Thalassemia Major | Status: COMPLETED